Research shows that weight regain varies widely
Supply and counterfeit risks Both agents have faced global shortages or stock issues and emerging counterfeit supply chains
While the precise reason has not yet been determined, its most likely a side effect of the weight loss itself, not the medication
Lipohypertrophy can change your pharmacokinetic profile unpredictably, making timing optimization pointless because you no longer know how fast the drug is reaching your bloodstream
Individuals should refrain from unauthorized off-label use, as it poses significant risks [Reference Eguale, Buckeridge, Verma, Winslade, Benedetti and Hanley48]
For anyone making a decision today, the comparison is lopsided in one specific sense: tirzepatide is an option you can actually be prescribed, with an approved label, a regulated supply chain, and accumulating post-market safety data